• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.

作者信息

Pasvolsky Oren, Saliba Rima M, Masood Adeel, Mohamedi Ali H, Tanner Mark R, Bashir Qaiser, Srour Samer, Saini Neeraj, Ramdial Jeremy, Nieto Yago, Lee Hans C, Patel Krina K, Kebriaei Partow, Thomas Sheeba K, Weber Donna M, Orlowski Robert Z, Shpall Elizabeth J, Champlin Richard E, Qazilbash Muzaffar H

机构信息

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.

出版信息

Br J Haematol. 2023 May;201(4):e37-e41. doi: 10.1111/bjh.18753. Epub 2023 Mar 14.

DOI:10.1111/bjh.18753
PMID:36916461
Abstract
摘要

相似文献

1
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.性别对接受自体造血干细胞移植的多发性骨髓瘤患者结局的影响。
Br J Haematol. 2023 May;201(4):e37-e41. doi: 10.1111/bjh.18753. Epub 2023 Mar 14.
2
Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.在恶性淋巴瘤或多发性骨髓瘤患者中，在使用粒细胞集落刺激因子的基础上加用普乐沙福用于造血干细胞动员以进行自体移植。
Cochrane Database Syst Rev. 2015 Oct 20;2015(10):CD010615. doi: 10.1002/14651858.CD010615.pub2.
3
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.苯达莫司汀、泼尼松和硼替佐米（BPV）预处理后在新诊断多发性骨髓瘤患者中的干细胞动员及自体干细胞移植
J Cancer Res Clin Oncol. 2015 Nov;141(11):2013-22. doi: 10.1007/s00432-015-1984-4. Epub 2015 May 15.
4
Impact of diet and antibiotics on gut microbiota and outcomes in patients with multiple myeloma treated with autologous hematopoietic stem cell transplantation.饮食和抗生素对接受自体造血干细胞移植治疗的多发性骨髓瘤患者肠道微生物群及预后的影响。
Leuk Lymphoma. 2023 Jan;64(1):3-4. doi: 10.1080/10428194.2022.2148219. Epub 2022 Nov 18.
5
Edentulism and transplant-associated complications in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.多发性骨髓瘤患者接受自体造血干细胞移植时的无牙状态及移植相关并发症。
Support Care Cancer. 2016 Aug;24(8):3411-5. doi: 10.1007/s00520-016-3168-4. Epub 2016 Mar 17.
6
Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis.自体移植对伴有 t(11;14)的多发性骨髓瘤患者的影响：倾向评分匹配分析。
Clin Cancer Res. 2019 Nov 15;25(22):6781-6787. doi: 10.1158/1078-0432.CCR-19-0706. Epub 2019 Sep 3.
7
Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma.自体造血干细胞移植后早期 M 蛋白免疫重建是高危细胞遗传学多发性骨髓瘤患者的良好预后标志物。
Br J Haematol. 2024 Mar;204(3):976-987. doi: 10.1111/bjh.19275. Epub 2024 Jan 21.
8
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation.缺乏护理人员与接受自体干细胞移植的骨髓瘤患者的生存时间更短有关。
Leuk Lymphoma. 2022 Oct;63(10):2422-2427. doi: 10.1080/10428194.2022.2074993. Epub 2022 May 12.
9
High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials.高剂量疗法联合单次自体移植与化疗治疗新诊断的多发性骨髓瘤：一项随机对照试验的系统评价和荟萃分析
Biol Blood Marrow Transplant. 2007 Feb;13(2):183-96. doi: 10.1016/j.bbmt.2006.09.010.
10
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.年龄是接受 upfront 自体造血干细胞移植的多发性骨髓瘤患者总生存的预后因素。
Biol Blood Marrow Transplant. 2020 Jun;26(6):1077-1083. doi: 10.1016/j.bbmt.2019.11.028. Epub 2019 Nov 29.

引用本文的文献

1
Advanced quantification pipeline reveals new spatial and temporal tumor characteristics in preclinical multiple myeloma.先进的定量分析流程揭示了临床前多发性骨髓瘤新的空间和时间肿瘤特征。
EJNMMI Res. 2025 Jul 31;15(1):95. doi: 10.1186/s13550-025-01291-x.
2
Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study).多发性骨髓瘤及相关肾肺损伤的药物治疗方法分析：大湾地区的一项回顾性真实世界注册研究（REPAIR研究）
Front Oncol. 2025 May 9;15:1547138. doi: 10.3389/fonc.2025.1547138. eCollection 2025.
3
Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT).
自体造血干细胞移植治疗初诊多发性骨髓瘤的全球特征和结局：全球血液和骨髓移植网络（WBMT）的研究。
Am J Hematol. 2024 Nov;99(11):2084-2095. doi: 10.1002/ajh.27451. Epub 2024 Aug 19.